Management will host a conference call at 8:00 am ET to review the quarterly figures and field questions from stakeholders. Participants planning to join via teleconference must register in advance to receive a personalized dial-in number and PIN. Access to a live webcast is available through the company’s investor relations portal, with an archived replay scheduled to remain accessible for one year starting at 11:00 am ET on the day of the announcement.

Haemonetics operates across the apheresis and medical-surgical sectors, focusing on blood management and interventional technologies. Investors may reach out to Olga Guyette or David Trenk for further inquiries regarding the fiscal update.